Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

6.46
Delayed Data
As of 3:59pm ET
 -0.03 / -0.46%
Today’s Change
3.50
Today|||52-Week Range
6.64
+40.43%
Year-to-Date
No recent news for Chimerix Inc.

Today’s Trading

Previous close6.49
Today’s open6.59
Day’s range6.42 - 6.59
Volume274,978
Average volume (3 months)488,013
Market cap$302.1M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+38.20%
Earnings growth (this year)-1.01%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.02%
P/E ratioNM
Price/Sales37.33
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...+0.03+0.37%
PTCTPTC Therapeutics Inc+0.07+0.83%
ADXSAdvaxis Inc+0.08+1.02%
SVASinovac Biotech Ltd+0.01+0.17%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$5.7M
Annual profit (last year)-$76.4M
Net profit margin-1,339.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
M. Michelle Berrey
Chief Financial Officer, Secretary &
Senior VP
Timothy W. Trost
Corporate headquarters
Durham, North Carolina

Forecasts


Search for Jobs